[email protected] & No phone number available.

Christos Monovoukas

EXECUTIVE SUMMARY Highly collaborative, influential, and accomplished Healthcare Senior Executive with demonstrated ability to drive company growth tightly aligned... | Greater Boston, Greater Boston, United States

*50 free lookup(s) per month.

No credit card required.

Christos Monovoukas’s Emails [email protected]

Christos Monovoukas’s Phone Numbers No phone number available.

Social Media

Christos Monovoukas’s Location Greater Boston, Greater Boston, United States

Christos Monovoukas’s Expertise EXECUTIVE SUMMARY Highly collaborative, influential, and accomplished Healthcare Senior Executive with demonstrated ability to drive company growth tightly aligned with corporate strategy. Leadership experience spans all functional areas including M&A, venture investing, business development, corporate strategy, and operations. Harvard MBA, Columbia University MS Mechanical Engineering. EXPERTISE Corporate Development / M&A, Ventures Technology Commercialization P&L / Operations Management New Market Development / Expansion Product Development / Launch Startup / Turnaround / Growth Strategy Development / Execution FDA / CE Mark / GMP Regulations Leadership / Staff Development SELECT LEADERSHIP CONTRIBUTIONS  Led Zimmer Biomet’s M&A team. Closed 5 deals in one year (Embody, Tightline, Avitus, Medstrat, and VIMS).  Architected Zimmer Biomet’s Corporate Venture fund, a new growth initiative for the company.  Developed and drove Olympus’ 5-year strategic planning process (2 billion business with 6 separate Business Units).  Led strategic acquisitions that transformed Olympus Corporation (Quest Photonic, Veran, FH Ortho, ARC, Image Stream).  Built and led Olympus Innovation Ventures, a 50 million Corporate Venture fund.  Key role in providing equity investment to Medi-Tate in a structured deal (Israeli startup company in urology market).  Key role in acquiring Healthpoint Biotherapeutics for 782 million (Smith & Nephew’s largest acquisition at the time, 2012).  Built Levitronix’ annual revenue from 12 million to 50 million in less than 2 years. Sold company to Thoratec for 150 million.  Key role in growing IntelliSense’s business from startup. Sold company to Corning, Inc. for 750 million.  Past board member of MassMedic (Largest regional MedTech association in the US).

Christos Monovoukas’s Current Industry Vessi Medical

Not the Christos Monovoukas you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Vessi Medical

Chairman of the Board

Sat Jun 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Zsquare

Business Advisor

Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Nina Medical

Member Board of Directors

Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Zimmer Biomet

VP, Business Development & Ventures

Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Olympus Corporation Of The Americas

VP, Global M&A Leader / Business Development & Ventures

Mon Apr 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Olympus Corporation Of The Americas

VP of Business Development and Strategy

Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Apr 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Smith And Nephew

VP, Strategic New Business Development

Mon Mar 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu May 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)

Pharos

Vice President, New Business Development & Ventures – Pharos, LLC

Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Dec 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Corning Intellisense

General Manager

Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)

Corning Intellisense

Director of Business Development - IntelliSense Corp.

Fri Jan 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)

Mckinsey

MBA Summer Intern

Thu Jan 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time)

Vital Insite

Product Development Manager, Electromechanical Group

Wed Jan 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time)

Raychem

Senior Manufacturing Engineer, PolySwitch Division

Sat Jan 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time)

Moore Business Forms

Senior Mechanical Engineer, R&D, Moore Research Center

Fri Jan 01 1988 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time)

Skills

Languages

Christos Monovoukas Email Addresses

[email protected] Email

Christos Monovoukas Phone Number

No phone number available. Phone number

FAQ About Christos Monovoukas

Christos Monovoukas is located at
Greater Boston, Greater Boston, United States

Christos Monovoukas is a
EXECUTIVE SUMMARY Highly collaborative, influential, and accomplished Healthcare Senior Executive with demonstrated ability to drive company growth tightly aligned with corporate strategy. Leadership experience spans all functional areas including M&A, venture investing, business development, corporate strategy, and operations. Harvard MBA, Columbia University MS Mechanical Engineering. EXPERTISE Corporate Development / M&A, Ventures Technology Commercialization P&L / Operations Management New Market Development / Expansion Product Development / Launch Startup / Turnaround / Growth Strategy Development / Execution FDA / CE Mark / GMP Regulations Leadership / Staff Development SELECT LEADERSHIP CONTRIBUTIONS  Led Zimmer Biomet’s M&A team. Closed 5 deals in one year (Embody, Tightline, Avitus, Medstrat, and VIMS).  Architected Zimmer Biomet’s Corporate Venture fund, a new growth initiative for the company.  Developed and drove Olympus’ 5-year strategic planning process (2 billion business with 6 separate Business Units).  Led strategic acquisitions that transformed Olympus Corporation (Quest Photonic, Veran, FH Ortho, ARC, Image Stream).  Built and led Olympus Innovation Ventures, a 50 million Corporate Venture fund.  Key role in providing equity investment to Medi-Tate in a structured deal (Israeli startup company in urology market).  Key role in acquiring Healthpoint Biotherapeutics for 782 million (Smith & Nephew’s largest acquisition at the time, 2012).  Built Levitronix’ annual revenue from 12 million to 50 million in less than 2 years. Sold company to Thoratec for 150 million.  Key role in growing IntelliSense’s business from startup. Sold company to Corning, Inc. for 750 million.  Past board member of MassMedic (Largest regional MedTech association in the US). Vessi Medical

Christos Monovoukas currently works in the
Vessi Medical

Christos Monovoukas specializes in
EXECUTIVE SUMMARY Highly collaborative, influential, and accomplished Healthcare Senior Executive with demonstrated ability to drive company growth tightly aligned with corporate strategy. Leadership experience spans all functional areas including M&A, venture investing, business development, corporate strategy, and operations. Harvard MBA, Columbia University MS Mechanical Engineering. EXPERTISE Corporate Development / M&A, Ventures Technology Commercialization P&L / Operations Management New Market Development / Expansion Product Development / Launch Startup / Turnaround / Growth Strategy Development / Execution FDA / CE Mark / GMP Regulations Leadership / Staff Development SELECT LEADERSHIP CONTRIBUTIONS  Led Zimmer Biomet’s M&A team. Closed 5 deals in one year (Embody, Tightline, Avitus, Medstrat, and VIMS).  Architected Zimmer Biomet’s Corporate Venture fund, a new growth initiative for the company.  Developed and drove Olympus’ 5-year strategic planning process (2 billion business with 6 separate Business Units).  Led strategic acquisitions that transformed Olympus Corporation (Quest Photonic, Veran, FH Ortho, ARC, Image Stream).  Built and led Olympus Innovation Ventures, a 50 million Corporate Venture fund.  Key role in providing equity investment to Medi-Tate in a structured deal (Israeli startup company in urology market).  Key role in acquiring Healthpoint Biotherapeutics for 782 million (Smith & Nephew’s largest acquisition at the time, 2012).  Built Levitronix’ annual revenue from 12 million to 50 million in less than 2 years. Sold company to Thoratec for 150 million.  Key role in growing IntelliSense’s business from startup. Sold company to Corning, Inc. for 750 million.  Past board member of MassMedic (Largest regional MedTech association in the US).

Christos Monovoukas speaks the following languages:
No languages available.

Christos Monovoukas has prior experience in the following industries:
Zimmer Biomet , Olympus Corporation Of The Americas , Olympus Corporation Of The Americas , Smith And Nephew , Pharos , Corning Intellisense , Corning Intellisense , Mckinsey , Vital Insite , Raychem , Moore Business Forms

Christos Monovoukas has the following professional experience:
Vessi Medical , Zsquare , Nina Medical , Zimmer Biomet , Olympus Corporation Of The Americas , Olympus Corporation Of The Americas , Smith And Nephew , Pharos , Corning Intellisense , Corning Intellisense , Mckinsey , Vital Insite , Raychem , Moore Business Forms .